Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132


Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate.

Judge RA, Scott VE, Simler GH, Pratt SD, Namovic MT, Putman CB, Aguirre A, Stoll VS, Mamo M, Swann SI, Hobson AD.

Chembiochem. 2018 Jan 4. doi: 10.1002/cbic.201700547. [Epub ahead of print]


Demagnetizing fields in all-optical switching.

Hoveyda F, Hohenstein E, Judge R, Smadici S.

J Phys Condens Matter. 2018 Jan 24;30(3):035801. doi: 10.1088/1361-648X/aa9e39.


A comparative study of encode protocol versus conventional protocol for restoring single implants: One-year prospective randomized controlled clinical trial.

Abduo J, Gade L, Gill H, Judge R, Darby I.

Clin Implant Dent Relat Res. 2017 Dec;19(6):1061-1067. doi: 10.1111/cid.12541. Epub 2017 Sep 21.


Effect of Implant Diameter And Alloy on Peri-Implant Strain: An In Vitro Quantitative Strain Analysis.

Goonawardhana D, Judge R, Palamara J, Abduo J.

Eur J Prosthodont Restor Dent. 2016 Dec;24(3):181-185. doi: 10.1922/EJPRD_1558Goonawardhana05.


The Effect of Coded Healing Abutments on Treatment Duration and Clinical Outcome: A Randomized Controlled Clinical Trial Comparing Encode and Conventional Impression Protocols.

Abduo J, Chen C, Le Breton E, Radu A, Szeto J, Judge R, Darby I.

Int J Oral Maxillofac Implants. 2017 September/October;32(5):1172–1179. doi: 10.11607/jomi.5386. Epub 2017 Mar 23.


Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8.

Judge RA, Zhu H, Upadhyay AK, Bodelle PM, Hutchins CW, Torrent M, Marin VL, Yu W, Vedadi M, Li F, Brown PJ, Pappano WN, Sun C, Petros AM.

ACS Med Chem Lett. 2016 Oct 11;7(12):1102-1106. eCollection 2016 Dec 8.


Creation of a S1P Lyase bacterial surrogate for structure-based drug design.

Argiriadi MA, Banach D, Radziejewska E, Marchie S, DiMauro J, Dinges J, Dominguez E, Hutchins C, Judge RA, Queeney K, Wallace G, Harris CM.

Bioorg Med Chem Lett. 2016 May 1;26(9):2293-6. doi: 10.1016/j.bmcl.2016.02.084. Epub 2016 Mar 3.


Three-dimensional structure, binding, and spectroscopic characteristics of the monoclonal antibody 43.1 directed to the carboxyphenyl moiety of fluorescein.

Gayda S, Longenecker KL, Judge RA, Swift KM, Manoj S, Linthicum DS, Tetin SY.

Biopolymers. 2016 Apr;105(4):234-43. doi: 10.1002/bip.22801.


Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.

Fitzpatrick JM, Biswas JS, Edgeworth JD, Islam J, Jenkins N, Judge R, Lavery AJ, Melzer M, Morris-Jones S, Nsutebu EF, Peters J, Pillay DG, Pink F, Price JR, Scarborough M, Thwaites GE, Tilley R, Walker AS, Llewelyn MJ; United Kingdom Clinical Infection Research Group.

Clin Microbiol Infect. 2016 Mar;22(3):244-51. doi: 10.1016/j.cmi.2015.10.034. Epub 2015 Nov 11.


Correction to Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity.

Bruncko M, Wang L, Sheppard GS, Phillips DC, Tahir SK, Xue J, Erickson S, Fidanze S, Fry E, Hasvold L, Jenkins GJ, Jin S, Judge RA, Kovar PJ, Madar D, Nimmer P, Park C, Petros AM, Rosenberg SH, Smith ML, Song X, Sun C, Tao ZF, Wang X, Xiao Y, Zhang H, Tse C, Leverson JD, Elmore SW, Souers AJ.

J Med Chem. 2015 May 14;58(9):4089. doi: 10.1021/acs.jmedchem.5b00616. Epub 2015 May 1. No abstract available.


Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity.

Bruncko M, Wang L, Sheppard GS, Phillips DC, Tahir SK, Xue J, Erickson S, Fidanze S, Fry E, Hasvold L, Jenkins GJ, Jin S, Judge RA, Kovar PJ, Madar D, Nimmer P, Park C, Petros AM, Rosenberg SH, Smith ML, Song X, Sun C, Tao ZF, Wang X, Xiao Y, Zhang H, Tse C, Leverson JD, Elmore SW, Souers AJ.

J Med Chem. 2015 Mar 12;58(5):2180-94. doi: 10.1021/jm501258m. Epub 2015 Feb 26. Erratum in: J Med Chem. 2015 May 14;58(9):4089.


Survival rates and complication types for single implants provided at the Melbourne Dental School.

Guo Q, Lalji R, Le AV, Judge RB, Bailey D, Thomson W, Escobar K.

Aust Dent J. 2015 Sep;60(3):353-61. doi: 10.1111/adj.12248.


Analysis of commonly reported medical conditions amongst patients receiving dental implant therapy in private practice.

Austin S, Bailey D, Chandu A, Dastaran M, Judge R.

Aust Dent J. 2015 Sep;60(3):343-52. doi: 10.1111/adj.12237.


Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity.

Tao ZF, Hasvold L, Wang L, Wang X, Petros AM, Park CH, Boghaert ER, Catron ND, Chen J, Colman PM, Czabotar PE, Deshayes K, Fairbrother WJ, Flygare JA, Hymowitz SG, Jin S, Judge RA, Koehler MF, Kovar PJ, Lessene G, Mitten MJ, Ndubaku CO, Nimmer P, Purkey HE, Oleksijew A, Phillips DC, Sleebs BE, Smith BJ, Smith ML, Tahir SK, Watson KG, Xiao Y, Xue J, Zhang H, Zobel K, Rosenberg SH, Tse C, Leverson JD, Elmore SW, Souers AJ.

ACS Med Chem Lett. 2014 Aug 26;5(10):1088-93. doi: 10.1021/ml5001867. eCollection 2014 Oct 9.


Fracture force of cantilevered zirconia frameworks: an in vitro study.

Chong KK, Palamara J, Wong RH, Judge RB.

J Prosthet Dent. 2014 Oct;112(4):849-56. doi: 10.1016/j.prosdent.2014.04.016. Epub 2014 May 16.


Water channel in the binding site of a high affinity anti-methotrexate antibody.

Gayda S, Longenecker KL, Manoj S, Judge RA, Saldana SC, Ruan Q, Swift KM, Tetin SY.

Biochemistry. 2014 Jun 17;53(23):3719-26. doi: 10.1021/bi5001382. Epub 2014 Jun 5.


Implications of implant framework misfit: a systematic review of biomechanical sequelae.

Abduo J, Judge RB.

Int J Oral Maxillofac Implants. 2014 May-Jun;29(3):608-21. doi: 10.11607/jomi.3418. Review.


Neutron structure of the cyclic glucose-bound xylose isomerase E186Q mutant.

Munshi P, Snell EH, van der Woerd MJ, Judge RA, Myles DA, Ren Z, Meilleur F.

Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):414-20. doi: 10.1107/S1399004713029684. Epub 2014 Jan 29.


Supplemental Content

Loading ...
Support Center